Compounds > anidulafungin
Page last updated: 2024-09-05

anidulafungin and Peritonitis

anidulafungin has been researched along with Peritonitis in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (80.00)24.3611
2020's1 (20.00)2.80

Authors

AuthorsStudies
Alvarez, ME; Cuenca-Estrella, M; Fortun, J; Gioia, F; Gomez-García de la Pedrosa, E; Gomez-Lopez, A; Martín-Davila, P; Moreno, S1
Holtappels, M; Kucharíková, S; Lagrou, K; Lamkanfi, M; Rogiers, O; Siala, W; Van Bambeke, F; Van Dijck, P1
Azanza Perea, JR; García-Montoto Pérez, F; Jerez Gómez-Coronado, V; Pazos Pacheco, C; Pérez Civantos, DV; Robles Marcos, M1
Álvarez-Escudero, J; Dominguez, D; Giménez, MJ; González-Serrano, M; Granizo, JJ; Maseda, E; Mouriz, L; Ojeda, N; Rodríguez-Manzaneque, M; Sánchez-Zamora, P1
Sganga, G1

Other Studies

5 other study(ies) available for anidulafungin and Peritonitis

ArticleYear
Pharmacokinetics of echinocandins in suspected candida peritonitis: A potential risk for resistance.
    International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2020, Volume: 101

    Topics: Adult; Anidulafungin; Antifungal Agents; Candida glabrata; Candidiasis; Caspofungin; Critical Illness; Echinocandins; Female; Humans; Male; Micafungin; Microbial Sensitivity Tests; Peritonitis; Prospective Studies

2020
Anidulafungin increases the antibacterial activity of tigecycline in polymicrobial Candida albicans/Staphylococcus aureus biofilms on intraperitoneally implanted foreign bodies.
    The Journal of antimicrobial chemotherapy, 2018, 10-01, Volume: 73, Issue:10

    Topics: Anidulafungin; Animals; Anti-Bacterial Agents; Antifungal Agents; Biofilms; Candida albicans; Candidiasis; Coinfection; Disease Models, Animal; Drug Synergism; Flow Cytometry; Foreign Bodies; Mice, Inbred BALB C; Microbial Sensitivity Tests; Microscopy, Electron, Scanning; Peritonitis; Staphylococcal Infections; Staphylococcus aureus; Tigecycline; Treatment Outcome

2018
Pharmacokinetics of anidulafungin in critically ill patients with Candida peritonitis.
    International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2019, Volume: 86

    Topics: Aged; Aged, 80 and over; Anidulafungin; Antifungal Agents; APACHE; Area Under Curve; Ascitic Fluid; Candida; Candidiasis; Critical Illness; Echinocandins; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Peritonitis; Prospective Studies

2019
Intraabdominal candidiasis in surgical ICU patients treated with anidulafungin: A multicenter retrospective study.
    Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, 2016, Volume: 29, Issue:1

    Topics: Abdomen; Abdominal Abscess; Adult; Aged; Aged, 80 and over; Anidulafungin; Antifungal Agents; Candida albicans; Candida glabrata; Candidiasis; Critical Care; Echinocandins; Female; Hospital Mortality; Humans; Length of Stay; Male; Middle Aged; Peritonitis; Retrospective Studies; Shock, Septic; Spain; Treatment Outcome

2016
Case report 4: Elderly patient with concomitant conditions.
    Mycoses, 2010, Volume: 53 Suppl 2

    Topics: Aged; Anidulafungin; Antifungal Agents; Bacteremia; Candida; Candidiasis; Echinocandins; Enterococcus faecalis; Female; Fungemia; Gram-Positive Bacterial Infections; Humans; Injections, Intravenous; Peritonitis; Radiography, Abdominal; Tomography, X-Ray Computed

2010